We have observed
7 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 27, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
CONTROLLED HNO RELEASE THROUGH INTRAMOLECULAR CYCLIZATION-ELIMINATION
PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS
NITROXYL DONORS WITH IMPROVED THERAPEUTIC INDEX
METHODS OF CELL SEPARATION
N-HYDROXYLSULFONAMIDE DERIVATIVES AS NEW PHYSIOLOGICALLY USEFUL NITROXYL DONORS
N-HYDROXYMETHANESULFONAMIDE NITROXYL DONORS
TEMPLATE-ASSISTED PRODUCTION OF POROUS MATERIALS